Melanoma Focus Virtual Regional Meeting
Friday 12th May 2023
Organised by: Professor Marianne Nicolson, Consultant Medical Oncologist, Raigmore Hospital, Inverness
Location: Virtual
Registration for this event is now open
| Friday, 12th May 2023 | 9:00 am – 5:30 pm |
CPD Applications for CME to the Federation of the Royal Colleges of Physicians of the United Kingdom, The Royal College of Surgeons of England and the British Association of Plastic, Reconstructive and Aesthetic Surgeons are in process.
If you are unsure about your membership, please email memberships@melanomafocus.org
Please submit your poster abstracts by 16th April 2023 (250 words maximum) to Michelle at mbridge@melanomafocus.org
Early bird rate ends April 16th 2023
EARLY BIRD REGISTRATION
| Delegate Type: | |
|---|---|
| Members (£25-£89) | Open form: |
| Non-Members (£45-£129) | Open form: |
| Industry (£169) | Open form: |
DRAFT PROGRAMME
| 09:00-09:15 | Welcome/Introductions (Dr Mark Harries / Susanna Daniels) |
| 09:15-10:00 | Neoadjuvant treatment of melanoma Professor Paolo Ascierto, Director of the Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, National Tumor Institute Fondazione G. Pascale, Naples |
| 10:10-11:25 | Session 1: Progress in stage 2/3 melanoma Chair: Professor Marianne Nicolson, Consultant Medical Oncologist, Raigmore Hospital, Inverness |
| 10:10 – 10:40 | Adjuvant therapy for resected melanoma – where are we now? Dr Pippa Corrie, Consultant Medical Oncologist, Cambridge University Hospitals NHS Foundation Trust |
| 10:40 – 11:10 | SLNB: An update on accuracy and eligibility Mr Neil Cahoon, Consultant Plastic Surgeon, Edinburgh |
| 11:10 – 11:25 | Q&A |
| 11:25 – 13:30 | Pharma Exhibition Area / Posters |
| 11:30– 12:30 | Pharma Sponsored Symposium: IMMUNOCORE
KIMMTRAK (Tebentafusp) – A New Treatment Option for patients with HLA-A*02:01 positive metastatic Uveal Melanoma
NHS Real World Experience and Future Service Considerations |
| 13:30 – 14:45 | Session 2: Optimising diagnosis today and new horizons for tomorrow Chair: Dr Ewan Brown, Consultant Medical Oncologist, Western General Hospital, Edinburgh |
| 13:30 – 14:00 | Diagnostic dilemmas in melanocytic pathology Dr Asok Biswas, Consultant Dermatopathologist and Honorary Senior Lecturer, Weston General Hospital and The University of Edinburgh |
| 14:00 – 14:30 | Melanoma translational research (tbc) |
| 14:30 – 14:45 | Q&A |
| 14:45 – 14:55 | Comfort Break |
| 14:55 – 16:10 | Session 3: Teledermatology practice changes Chair: Mr Kaz Rahman, Consultant Plastic Surgeon, NHS Grampian & Clinical Director for Skin Cancer, North Cancer Alliance |
| 14:55 – 15:25 | Enhancement of clinical practice through teledermatology Dr Alyson Bryden, Consultant Dermatologist, Ninewells Hospital, Dundee |
| 15:25 – 15:55 | Digital healthcare intervention for melanoma survivors: the next steps? Professor Peter Murchie, Professor of General Practice, University of Aberdeen |
| 15:55 – 16:10 | Q&A |
| 16:15 – 17:25 | Session 4: MDT – Management of uveal melanoma (case-based discussions) Chair: Dr Paul Nathan, Consultant Medical Oncologist, Mount Vernon Cancer Centre |
| 17:25 – 17:30 | Concluding Remarks and Close Dr Mark Harries, Chairman Melanoma Focus, Professor Marianne Nicolson, Organiser |